← All news
Deals
hVIVO acquires CRS Berlin for dermatology, women’s health trials
2 outlets - including Investing and Kalkinemedia - are covering this story. hVIVO plc (AIM: HVO), a global frontrunner in human challenge trials listed on AIM, has completed the acquisition of CRS Clinical Research Services Berlin GmbH, a specialist Phase I/II clinical research unit based in Germany. This strategic…
Covered by 2 outlets
All coverage · 2 articles
Investing.com Canada
·Aug 27, 06:30 UTC
hVIVO acquires CRS Berlin for dermatology, women’s health trials
Kalkine Media UK
·Aug 27, 06:01 UTC
hVIVO plc (HVO) Expands Dermatology and Women's Health Clinical Trial Services with CRS Berlin Acquisition
hVIVO plc (AIM: HVO), a global frontrunner in human challenge trials listed on AIM, has completed the acquisition of CRS Clinical Research Services Berlin GmbH, a specialist Phase I/II clinical research unit based in Germany. This strategic…